Coronavirus disease 2019: What we know?

By Feng He, Yu Deng, Wei-na Li. Journal of Medical Virology, 2020

762 citations recorded by the source corpus.

In late December 2019, a cluster of unexplained pneumonia cases has been reported in Wuhan, China. A few days later, the causative agent of this mysterious pneumonia was identified as a novel coronavirus. This causative virus has been temporarily named as severe acute respiratory syndrome coronavirus 2 and the relevant infected disease has been named as coronavirus disease 2019 (COVID‐19) by the World Health Organization, respectively. The COVID‐19 epidemic is spreading in China and all over the world now. The purpose of this review is primarily to review the pathogen, clinical features, diagnosis, and treatment of COVID‐19, but also to comment briefly on the epidemiology and pathology based on the current evidence.

Subfields: Infectious Diseases, Modeling and Simulation

View Paper: https://www.semanticscholar.org/paper/1a7a77ede896637d488b019d9104aebdd77b60b2

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. Yunlei Deng
2. Qianwen Zhao
3. Meng Meng
4. Rahul Kumar
5. N. Lian
6. Jiaofeng Huang
7. Yinlian Wu
8. Su Lin

Citations in the corpus

• The impact of COPD and smoking history on the severity of COVID‐19: A systemic review and meta‐analysis (2020, background): “Coronavirus disease 2019 (COVID‐19) is now a declared pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS‐ CoV‐2).(1,2) Due to its extremely high infectivity, COVID‐19 has caused over 292142 infections and 12784 deaths worldwide as of 22 March 2020 (World Health Organization cor”